BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 2009
View Archived Issues
Tenecteplase restores function to occluded central venous catheters
Read More
Novel proteasome inhibitor NPI-0052 shows safety in phase I trials
Read More
Pharmacyclics presents phase I data on lymphoma agents
Read More
Studies find benefit with intravitreal dexamethasone implant in ocular indications
Read More
Abbott submits sNDA to FDA for new dosage strengths of Simcor
Read More
FDA approves Cequent's IND to initiate phase I clinical trial of CEQ-508 in FAP patients
Read More
Salix and FDA hold pre-NDA meeting on rifaximin therapy for non-constipation IBS
Read More
Vion receives complete response letter from FDA related to Onrigin NDA
Read More
Merck KGaA initiates phase III INSPIRE trial of Stimuvax in advanced NSCLC
Read More
Beneficial effects of SUN-11031 in COPD patients with cachexia reported
Read More
Novel FLAP inhibitor AM-679 reduces ocular pathology in RSV-infected mice
Read More
Takeda claims sGC activators for the treatment of hypertension
Read More
InNexus Biotechnology and Xeris to develop subcutaneous delivery of DXL antibodies
Read More
Kissei discovers SGLT-1 inhibitors for the treatment of diabetes
Read More
Janssen discloses GHS receptor agonists for gastrointestinal disorders
Read More
Lilly presents novel BACE inhibitors for Alzheimer's disease
Read More
FDA approves Azaya's IND to initiate phase I clinical trial of liposomal docetaxel
Read More
Genentech terminates dacetuzumab collaboration with Seattle Genetics
Read More
Celsion enrolls first patient in China in phase III trial of ThermoDox in HCC
Read More
Bayer Schering withdraws European MAA for Recothrom (thrombin alfa)
Read More
Bio-Quant becomes wholly owned subsidiary of NexMed
Read More
Elan and Transition Therapeutics modify phase II ELND-005 trial in AD
Read More
Welichem begins patient enrollment in phase IIb trial of WBI-1001 creams
Read More
Seattle Genetics and Millennium enter into strategic collaboration on SGN-35
Read More
Array BioPharma and Amgen partner for small-molecule glucokinase activator program
Read More
Polypeptide-doxorubicin conjugate nanoparticles display potent antitumor efficacy in vivo
Read More
